project id: TCGA-LUAD; case submitter id: TCGA-L9-A5IP; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; age at index: 40; days to birth: -14681; days to death: 58; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1972; year of death: 2012; age at diagnosis: 14681; ajcc pathologic m: M1b; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 94; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-L9-A5IP-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 20.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0;